| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/0008-5472.CAN-05-4527 |
| P698 | PubMed publication ID | 16651413 |
| P50 | author | George Coukos | Q46574285 |
| P2093 | author name string | Lin Zhang | |
| Jia Huang | |||
| Dionyssios Katsaros | |||
| Marco Massobrio | |||
| Barbara L Weber | |||
| Katherine F Roby | |||
| Nuo Yang | |||
| Shun Liang | |||
| Phyllis Gimotty | |||
| Ralf Butzow | |||
| Mark G Cadungog | |||
| Ann O'Brien-Jenkins | |||
| Antonis Giannakakis | |||
| Andrea Barchetti | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 4627-4635 | |
| P577 | publication date | 2006-05-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Integrative genomic analysis of protein kinase C (PKC) family identifies PKCiota as a biomarker and potential oncogene in ovarian carcinoma | |
| P478 | volume | 66 |
| Q35954798 | A mixed-methods feasibility trial of protein kinase C iota inhibition with auranofin in asymptomatic ovarian cancer patients |
| Q39642419 | A proteomic investigation of B lymphocytes in an autistic family: a pilot study of exposure to natural rubber latex (NRL) may lead to autism |
| Q37103690 | Actin cytoskeletal mediators of motility and invasion amplified and overexpressed in head and neck cancer |
| Q33888968 | Activation of the PKC pathway stimulates ovarian cancer cell proliferation, migration, and expression of MMP7 and MMP10. |
| Q98611521 | Addiction to protein kinase Cɩ due to PRKCI gene amplification can be exploited for an aptamer-based targeted therapy in ovarian cancer |
| Q27684030 | Adenosine-binding motif mimicry and cellular effects of a thieno[2,3-d]pyrimidine-based chemical inhibitor of atypical protein kinase C isoenzymes |
| Q40054747 | Amplification of PRKCI, located in 3q26, is associated with lymph node metastasis in esophageal squamous cell carcinoma |
| Q38660465 | Approaches to identify kinase dependencies in cancer signalling networks |
| Q37143104 | Atypical protein kinase C iota expression and aurothiomalate sensitivity in human lung cancer cells |
| Q35416040 | Atypical protein kinase C zeta: potential player in cell survival and cell migration of ovarian cancer |
| Q38162656 | Atypical protein kinase Cι as a human oncogene and therapeutic target |
| Q57271956 | Aurothiomalate Inhibits Transformed Growth by Targeting the PB1 Domain of Protein Kinase Cι |
| Q35037676 | Cancer-associated protein kinase C mutations reveal kinase's role as tumor suppressor |
| Q34089685 | Cellular Responses to Cisplatin‐Induced DNA Damage |
| Q37435101 | Chapter 3: acquisition of membrane polarity in epithelial tube formation patterns, signaling pathways, molecular mechanisms, and disease. |
| Q54593106 | Coexpression of aPKCλ/ι and IL-6 in prostate cancer tissue correlates with biochemical recurrence. |
| Q30496644 | Coordination of glioblastoma cell motility by PKCι |
| Q40236633 | Effects on ligand interaction and membrane translocation of the positively charged arginine residues situated along the C1 domain binding cleft in the atypical protein kinase C isoforms |
| Q39020777 | Ellagic acid induces novel and atypical PKC isoforms and promotes caspase-3 dependent apoptosis by blocking energy metabolism |
| Q101574540 | Equivocal, explicit and emergent actions of PKC isoforms in cancer |
| Q33403197 | Expression of activated PIK3CA in ovarian surface epithelium results in hyperplasia but not tumor formation. |
| Q33836807 | Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC). |
| Q34166257 | Genome wide DNA copy number analysis of serous type ovarian carcinomas identifies genetic markers predictive of clinical outcome |
| Q33440056 | High-resolution analysis of copy number alterations and associated expression changes in ovarian tumors |
| Q33553289 | Identification of candidate growth promoting genes in ovarian cancer through integrated copy number and expression analysis |
| Q36423540 | Instructive role of aPKCzeta subcellular localization in the assembly of adherens junctions in neural progenitors |
| Q47123431 | Integrated genomic analysis of clear cell ovarian cancers identified PRKCI as a potential therapeutic target |
| Q34209814 | Meta-analysis of gene expression profiles associated with histological classification and survival in 829 ovarian cancer samples. |
| Q28081405 | Molecular pathways: novel approaches for improved therapeutic targeting of Hedgehog signaling in cancer stem cells |
| Q37588487 | Of the atypical PKCs, Par-4 and p62: recent understandings of the biology and pathology of a PB1-dominated complex |
| Q30009453 | Overexpression of atypical protein kinase C in HeLa cells facilitates macropinocytosis via Src activation |
| Q35917907 | PDK1 in apical signaling endosomes participates in the rescue of the polarity complex atypical PKC by intermediate filaments in intestinal epithelia |
| Q24297584 | PKC-ι promotes glioblastoma cell survival by phosphorylating and inhibiting BAD through a phosphatidylinositol 3-kinase pathway |
| Q36869444 | PKCiota promotes ovarian tumor progression through deregulation of cyclin E. |
| Q37466903 | PKCι maintains a tumor-initiating cell phenotype that is required for ovarian tumorigenesis. |
| Q37520978 | PKCι regulates nuclear YAP1 localization and ovarian cancer tumorigenesis |
| Q47154650 | PRKCI promotes immune suppression in ovarian cancer |
| Q37333585 | Par complex in cancer: a regulator of normal cell polarity joins the dark side |
| Q37608855 | Phase I dose escalation study of the PKCι inhibitor aurothiomalate for advanced non-small-cell lung cancer, ovarian cancer, and pancreatic cancer. |
| Q95267290 | Phosphoproteomics Reveals Key Regulatory Kinases and Modulated Pathways Associated with Ovarian Cancer Tumors |
| Q36082365 | Phosphorylation of claudin-4 by PKCepsilon regulates tight junction barrier function in ovarian cancer cells |
| Q37333610 | Polarity proteins in migration and invasion |
| Q85855891 | Preclinical antitumor activity of a nanoparticulate SN38 |
| Q59072618 | Protein Kinase C (PKC) Isozymes and Cancer |
| Q38171231 | Protein kinase C and cancer: what we know and what we do not. |
| Q35987724 | Protein kinase C iota as a therapeutic target in alveolar rhabdomyosarcoma. |
| Q24652905 | Protein kinase C iota: human oncogene, prognostic marker and therapeutic target |
| Q36980701 | Protein kinase C isozymes as therapeutic targets for treatment of human cancers |
| Q39736038 | Protein kinase Ciota is required for pancreatic cancer cell transformed growth and tumorigenesis |
| Q37491175 | Protein kinase Cα suppresses Kras-mediated lung tumor formation through activation of a p38 MAPK-TGFβ signaling axis. |
| Q34787801 | Protein kinase Cι expression and oncogenic signaling mechanisms in cancer. |
| Q53722723 | Protein kinase Cι is a new prognostic factor in gastric cancer. |
| Q54314273 | Quantification of PKC family genes in sporadic breast cancer by qRT-PCR: evidence that PKCι/λ overexpression is an independent prognostic factor. |
| Q39453904 | Regulation of Cdk7 activity through a phosphatidylinositol (3)-kinase/PKC-ι-mediated signaling cascade in glioblastoma |
| Q34739540 | Regulation of glioblastoma cell invasion by PKC iota and RhoB. |
| Q37537542 | Regulation of polarized morphogenesis by protein kinase C iota in oncogenic epithelial spheroids. |
| Q35791117 | Relevant molecular markers and targets |
| Q39436597 | Repression of cancer cell senescence by PKCι. |
| Q35747051 | Role of ellagic acid in regulation of apoptosis by modulating novel and atypical PKC in lymphoma bearing mice |
| Q37673912 | Targeting oncogenic protein kinase Cι for treatment of mutant KRAS LADC. |
| Q52579980 | Targeting the protein kinase C family: are we there yet? |
| Q36301305 | The Par complex and integrins direct asymmetric cell division in adult intestinal stem cells |
| Q36510237 | The chromosome 3q26 OncCassette: A multigenic driver of human cancer |
| Q33827549 | The guanine nucleotide exchange factor (GEF) Ect2 is an oncogene in human cancer |
| Q38981224 | The interruption of PKC-ι signaling and TRAIL combination therapy against glioblastoma cells |
| Q24681466 | Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression |
| Q47671913 | Two novel PRKCI polymorphisms and prostate cancer risk in an Eastern Chinese Han population |
| Q28577615 | Wnt/beta-catenin signalling pathway following rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide |
| Q60044508 | aPKC controls endothelial growth by modulating c-Myc via FoxO1 DNA-binding ability |
| Q37364129 | aPKClambda/iota promotes growth of prostate cancer cells in an autocrine manner through transcriptional activation of interleukin-6. |
| Q24630894 | miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer |
Search more.